Your browser doesn't support javascript.
loading
Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy.
Treda, Cezary; Wlodarczyk, Aneta; Pacholczyk, Marcin; Rutkowska, Adrianna; Stoczynska-Fidelus, Ewelina; Kierasinska, Amelia; Rieske, Piotr.
Afiliação
  • Treda C; Department of Tumor Biology, Medical University of Lodz, Zeligowskiego 7/9, 90-752 Lodz, Poland.
  • Wlodarczyk A; Department of Research and Development, Celther Polska Ltd., Inwestycyjna 7, 95-050 Konstantynow Lodzki, Poland.
  • Pacholczyk M; Department of Tumor Biology, Medical University of Lodz, Zeligowskiego 7/9, 90-752 Lodz, Poland.
  • Rutkowska A; Department of Research and Development, Celther Polska Ltd., Inwestycyjna 7, 95-050 Konstantynow Lodzki, Poland.
  • Stoczynska-Fidelus E; Department of Research and Development, Celther Polska Ltd., Inwestycyjna 7, 95-050 Konstantynow Lodzki, Poland.
  • Kierasinska A; Department of Systems Biology and Engineering, Silesian University of Technology, Akademicka 16, 44-100 Gliwice, Poland.
  • Rieske P; Department of Tumor Biology, Medical University of Lodz, Zeligowskiego 7/9, 90-752 Lodz, Poland.
Int J Mol Sci ; 24(5)2023 Feb 22.
Article em En | MEDLINE | ID: mdl-36901782
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma / Receptores de Antígenos Quiméricos Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma / Receptores de Antígenos Quiméricos Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article